Quantum Immunologics’ Alternative to Chemotherapy
The company’s vaccine technology is based on the universal tumor antigen, which has been expressed in all human cancers studied so far.
Charles Broes
Quantum Immunologics at the 2010 OneMedForum
Charles Broes, CEO and Chairman of the Board of Quantum Immunologics, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San […]